Study details
Enrolling now
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
Yale University
NCT IDNCT05317455ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
16
Study length
about 1.1 years
Ages
18–55
Locations
1 site in CT
About this study
Researchers are testing if dichloroacetate can help restore brain glucose metabolism in people with type 1 diabetes who experience hypoglycemia unawareness. The trial will last for about 413 days and involves a total of approximately 16 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Dichloroacetate
PhaseEARLY_Phase 1
Primary goalCognitive Function
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Cognitive Function
Body systems
Endocrinology